Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > From Sedar

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Oct 06, 2020 8:14pm

332 Views

Post# 31678105

RE:From Sedar

Nice like I said before get the results of the next set or even at 9 months data on first set which is in 3 months and that will be enough to get warrants excercised and bring up to $10 million extra cash to get 2 PH1 trials done.

BencrosMum wrote:

Trends

The Company anticipates that its current level of cash and cash equivalents will be sufficient to execute its current planned expenditures for the next 18 to 24 months. This estimate assumes completion of Study II, but does not include pre-clinical research and validation of TLD-1433 used in GBM, NSCLC or viruses such as COVID-19 as it moves towards a Phase Ib study in which additional financing will be needed.

Just need to knock bladder out of the park